1. Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma. Issue 4 (12th May 2022) Authors: Wolfe, Zachary; Friedland, Julie C.; Ginn, Sarah; Blackham, Aaron; Demberger, Lauren; Horton, Morgan; McIntosh, Alyson; Sheikh, Hina; Box, Jessica; Knoerzer, Deborah; Federowicz, Bryan; Stuhlmiller, Timothy J.; Shapiro, Mark; Nair, Suresh Journal: Melanoma research Issue: Volume 32:Issue 4(2022) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. INNV-37. XCELSIOR: A REAL-TIME, REAL-WORLD LEARNING PLATFORM FOR PATIENTS WITH ADVANCED CANCER. (12th November 2021) Authors: Stuhlmiller, Timothy; Shapiro, Mark; Wasserman, Asher; Osking, Zachary; Shrager, Jeff; Federowicz, Bryan; Warner, Matthew; Friedland, Julie; Musella, Al; Blondin, Nicholas; Fonkem, Ekokobe; Wong, Eric; Kesari, Santosh Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. QOL-21. REAL-WORLD QUALITY-OF-LIFE AND HEALTH UTILITIES FOR PATIENTS WITH CNS CANCERS ON THE XCELSIOR PLATFORM. (14th November 2022) Authors: Sabates, Alanis; Wood, Alayna; Lee, Hope; Swain, Andrew; Irizarry, Sabrina; Hinton, Chezney; Ginn, Sarah; Cole, Zac; Chavez, Gordon; Tadic, Kristina; Chuyka, Don; Federowicz, Bryan; Proescholdt, Christina; Shapiro, Mark Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗